A new treatment for Alzheimer’s disease approved by the Food and Drug Administration this month is just the start, says UW Medicine behavioral neurologist Dr. Michael Rosenbloom.
Patients in need of cataract surgery also see their risk for developing dementia drop by 30% after undergoing the operation, according to new research published today in JAMA Internal Medicine.